Skip to content

Clinical trials

Recruiting Phase 1/2 Endometrial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20203
20215
20224
202311
20245
202510
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
GV20 Therapeutics2
Regeneron Pharmaceuticals2
Shenzhen Ionova Life Sciences Co., Ltd.2
858 Therapeutics, Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Alliance Foundation Trials, LLC.1
Artios Pharma Ltd1
Avenzo Therapeutics, Inc.1
Beijing Tide Pharmaceutical Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms45
Ovarian Neoplasms27
Colorectal Neoplasms16
Breast Neoplasms15
Carcinoma, Non-Small-Cell Lung15
Neoplasm Metastasis13
Neoplasms13
Uterine Cervical Neoplasms13
Squamous Cell Carcinoma of Head and Neck10
Stomach Neoplasms10

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.